Literature DB >> 19837296

Foot and mouth disease virus vaccines.

Luis L Rodriguez1, Marvin J Grubman.   

Abstract

Foot and mouth disease (FMD) is a highly infectious and economically devastating disease of livestock. Although vaccines, available since the early 1900s, have been instrumental in eradicating FMD from parts of the world, the disease still affects millions of animals around the globe and remains the main sanitary barrier to the commerce of animals and animal products. Currently available inactivated antigen vaccines applied intramuscularly to individual animals, confer serotype and subtype specific protection in 1-2 weeks but fail to induce long-term protective immunity. Among the limitations of this vaccine are potential virus escape from the production facility, short shelf life of formulated product, short duration of immunity and requirement of dozens of antigens to address viral antigenic diversity. Here we review novel vaccine approaches that address some of these limitations. Basic research and the combination of reliable animal inoculation models, reverse genetics and computational biology tools will allow the rational design of safe and effective FMD vaccines. These vaccines should address not only the needs of FMD-free countries but also allow the progressive global control and eradication of this devastating disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19837296     DOI: 10.1016/j.vaccine.2009.08.039

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  52 in total

Review 1.  Developments in high-yield system expressed vaccines and immunotherapy.

Authors:  Marissa Geels; Kaiming Ye
Journal:  Recent Pat Biotechnol       Date:  2010-11

2.  Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle.

Authors:  Eva Perez-Martin; Marcelo Weiss; Fayna Diaz-San Segundo; Juan M Pacheco; Jonathan Arzt; Marvin J Grubman; Teresa de los Santos
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

3.  Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in guinea pigs and sheep.

Authors:  Jun-jun Shao; Jing-feng Wang; Hui-yun Chang; Ji-xing Liu
Journal:  Virol Sin       Date:  2011-06-12       Impact factor: 4.327

4.  Two distinct conformations of a rinderpest virus epitope presented by bovine major histocompatibility complex class I N*01801: a host strategy to present featured peptides.

Authors:  Xin Li; Jun Liu; Jianxun Qi; Feng Gao; Qirun Li; Xiaoying Li; Nianzhi Zhang; Chun Xia; George F Gao
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

5.  A Temperature-Dependent Translation Defect Caused by Internal Ribosome Entry Site Mutation Attenuates Foot-and-Mouth Disease Virus: Implications for Rational Vaccine Design.

Authors:  Decheng Yang; Chao Sun; Rongyuan Gao; Haiwei Wang; Wenming Liu; Kewei Yu; Guohui Zhou; Bo Zhao; Li Yu
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

6.  Comparison of strategies for the production of FMDV empty capsids using the baculovirus vector system.

Authors:  V Ruiz; A C Mignaqui; M C Nuñez; E Reytor; J M Escribano; A Wigdorovitz
Journal:  Mol Biotechnol       Date:  2014-11       Impact factor: 2.695

7.  Enhanced Efficacy of Immunization with a Foot-and-Mouth Disease Multi-Epitope Subunit Vaccine Using Mannan-Decorated Inulin Microparticles.

Authors:  So-Yeon Yoon; Sang-Kee Kang; Ho-Bin Lee; Seo-Ho Oh; Whee-Soo Kim; Hui-Shan Li; Jin-Duck Bok; Chong-Su Cho; Yun-Jaie Choi
Journal:  Tissue Eng Regen Med       Date:  2019-12-09       Impact factor: 4.169

8.  Constitutively Active IRF7/IRF3 Fusion Protein Completely Protects Swine against Foot-and-Mouth Disease.

Authors:  Lisbeth Ramírez-Carvajal; Fayna Diaz-San Segundo; Elizabeth Ramirez-Medina; Luis L Rodríguez; Teresa de Los Santos
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

9.  Expression of porcine fusion protein IRF7/3(5D) efficiently controls foot-and-mouth disease virus replication.

Authors:  Lisbeth Ramírez-Carvajal; Fayna Díaz-San Segundo; Danielle Hickman; Charles R Long; James Zhu; Luis L Rodríguez; Teresa de los Santos
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

10.  A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals.

Authors:  Sabena Uddowla; Jason Hollister; Juan M Pacheco; Luis L Rodriguez; Elizabeth Rieder
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.